echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimer & Dementia: These plasma proteins are linked to cognitive decline and long-term risk of dementia

    Alzheimer & Dementia: These plasma proteins are linked to cognitive decline and long-term risk of dementia

    • Last Update: 2022-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Alzheimer's disease (AD) and related dementias pose a growing challenge, imposing enormous costs on personal, health and social care services


    Alzheimer's disease (AD) and related dementias pose a growing challenge, imposing enormous costs on personal, health and social care services


    Furthermore, longitudinal studies have shown that most cognitively normal amyloid-positive individuals never develop clinical dementia


    To this end, experts from the Department of Epidemiology and Public Health at UCL, UK, examined the association between 4,953 plasma proteins and the risk of cognitive decline and dementia in two cohort studies followed for 20 years.


    In the Whitehall II prospective cohort study, proteins were measured using the SOMAscan technique


    In the Whitehall II prospective cohort study, proteins were measured using the SOMAscan technique


    246 of the 4953 proteins were associated with an increased rate of cognitive decline


    In analyses adjusted for age, sex, and ethnicity/ethnicity, 1SD higher levels of each of the 15 proteins were associated with increased risk ranging from 8% to 64%


    This study identified several plasma proteins associated with cognitive decline and long-term risk of dementia in people without dementia


    This study identified several plasma proteins associated with cognitive decline and long-term risk of dementia in people without dementia


    references:

    references:

    Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.


    Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
    https://doi.
    org/10.
    1002/alz.
    12419 Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
    https://doi.
    org/10.
    1002/alz.
    12419

    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.